Inovio Pharmaceuticals
INO
INO
89 hedge funds and large institutions have $56.4M invested in Inovio Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
39% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 31
46% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 50
Holders
89
Holding in Top 10
–
Calls
$5.24M
Puts
$5.08M
Top Buyers
| 1 | +$3.23M | |
| 2 | +$1.48M | |
| 3 | +$1.08M | |
| 4 |
HF
HRT Financial
New York
|
+$901K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$722K |
Top Sellers
| 1 | -$3.28M | |
| 2 | -$2.19M | |
| 3 | -$1.38M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$733K |